Android app on Google Play

Accretive Health (AH) Misses Q2 EPS by 5c; Slashes FY12 EPS Outlook

August 8, 2012 7:47 AM EDT Send to a Friend
Get Alerts AH Hot Sheet
Trade AH Now!
Join SI Premium – FREE
Accretive Health (NYSE: AH) reported Q2 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $236.7 million versus the consensus estimate of $234.64 million.

Sees FY2012 EPS of $0.23-$0.27, versus prior guidance of $0.42-$0.50 and the consensus of $0.41.

For earnings history and earnings-related data on Accretive Health (AH) click here.

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Guidance

Related Entities


Add Your Comment